An IVF Company Bought 146,432 XRP Last Year, Then Sold It All

Key Takeaways

• Newgenivf’s Form F-1/A, filed Sept. 10, 2026, discloses SOL, BTC, ETH and XRP trading during 2025.
• The XRP round trip produced $10,849 of the company’s $942,915 in total realized crypto gains.
• Only 13,000.23 SOL remained at year-end, carrying a $1.28 million unrealized loss.

What The SEC Filings Actually Say

Buried in an amended registration statement from a fertility clinic operator with units in Cambodia and Kyrgyzstan is one of the stranger corporate crypto disclosures of the year.

Newgenivf Group Limited, which trades on the Nasdaq Capital Market as NIVF, filed Amendment No. 2 to its Form F-1 on Sept. 10. Note 8 of the financial statements, headed digital assets, states:

“[During the year ended Dec. 31, 2025] the company began investing excess treasury balances in certain digital assets, comprising solana (“SOL”), bitcoin (“BTC”), ethereum (“ETH”), and a the token native to the XRP Ledger (“XRP”), all of which are blockchain-based crypto assets, as part of its capital allocation strategy.”

The company’s disclosures made sure to add that its primary business was “in-vitro fertilization (“IVF”) services,” and that the digital asset activity was “not part of its core operating activities.”